› Forums › General Melanoma Community › First Infusion in LAG3 Trial Complete
- This topic has 3 replies, 3 voices, and was last updated 6 years, 10 months ago by UBContributor.
- Post
-
- June 23, 2017 at 7:42 pm
As promised, I wanted to come back to give everybody an update on my experience in the anti-LAG3 (BMS986016) trial at Johns Hopkins.
I had my first infusion on Tuesday (6/20). Pretty uneventful in my case. I received Opdivo first, followed by the experimental medication. Everything went smoothly and I have experienced no side effects so far. The research nurse who is overseeing all of us on the trial there told me that another patient who also started on Tuesday had an entire range of side effects. But I've been just fine. As I told her, I hope outwardly things go smoothly while on the inside it's eating up the cancer. But I won't know for sure until my first scans, which I think come at the end of the first or second 45 day treatment cycle.
My next infusion is on July 5 due to the holiday. I'll update again after that one, or sooner if I start noticing any side effects or anything else noteworthy.
-Bill
- Replies
- You must be logged in to reply to this topic.